Midline catheter use for cancer patients receiving 5-FU chemotherapy: prospective study of safety and outcomes
MLC insertion is a safe and effective approach for continuous 5-FU infusion, eliminating phlebitis, potentially improving patients' quality of life, and reducing healthcare providers' workloads. (ClinicalTrials.gov Identifier: jRCTs042230058).
Authors
- Yasunobu Ishizuka (ORCID: https://orcid.org/0009-0003-3305-4013)
- Aiko Ogawa (ORCID: https://orcid.org/0000-0003-2784-752X)
- Toshiki Masuishi (ORCID: https://orcid.org/0000-0002-7521-1596)
- Yukiya Narita (ORCID: https://orcid.org/0000-0002-8018-0077)
- Masashi Ando (ORCID: https://orcid.org/0000-0002-9537-8879)
- Kazunori Honda (ORCID: https://orcid.org/0000-0001-5090-9771)
- Shigenori Kadowaki (ORCID: https://orcid.org/0000-0001-9923-5309)
- Hiroya Taniguchi (ORCID: https://orcid.org/0000-0003-1407-6682)
- Tomoki Sakakida (ORCID: https://orcid.org/0000-0003-1913-7923)
- Kei Muro (ORCID: https://orcid.org/0000-0002-5572-743X)
- Susumu Fukahori (ORCID: https://orcid.org/0000-0003-2709-8880)
- Isao Oze (ORCID: https://orcid.org/0000-0002-0762-1147)
- Chiho Kudo (ORCID: https://orcid.org/0000-0002-1689-3566)
- Taro Mizuno
- Hiroyuki Kodama (ORCID: https://orcid.org/0000-0002-5194-2888)
- Munehiro Wakabayashi (ORCID: https://orcid.org/0009-0001-8844-6845)
Institutions
- Aichi Cancer Center (JP)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1093/oncolo/oyaf108
- Primary Topic
- Chemotherapy-related skin toxicity
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Aichi Cancer Research Foundation